Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Wednesday.

Shares of Flywire Corporation FLYW fell sharply in today's pre-market trading after the company reported worse-than-expected quarterly financial results.

Flywire reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.01) per share. The company reported quarterly sales of $117.600 million which missed the analyst consensus estimate of $118.917 million.

Flywire shares dipped 29.2% to $12.49 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

Liberty Global Ltd. LBTYK shares fell 40.4% to $7.12 in pre-market trading.
Accel Entertainment, Inc. ACEL dipped 31.2% to $8.12 in pre-market trading. Accel Entertainment will release its financial and operating results for the fourth quarter after market close on Feb. 27.
Grocery Outlet Holding Corp. GO shares fell 18.8% to $12.78 in pre-market trading after the company reported mixed fourth-quarter financial results and issued FY25 adjusted EPS guidance below estimates.
CareDx, Inc CDNA shares tumbled 18.1% to $17.12 in pre-market trading.
agilon health, inc. AGL fell 15.7% to $3.06 in pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results.
Lemonade, Inc. LMND fell 13.4% to $27.72 in today's pre-market trading after reporting fourth-quarter results.
Ginkgo Bioworks Holdings, Inc. DNA shares dipped 13% to $8.96 in pre-market trading after the company posted weak quarterly results.
NewAmsterdam Pharma Company N.V. NAMS fell 11.3% to $87.00 in pre-market trading.
Maplebear Inc. CART dipped 11% to $43.40 in pre-market trading after the company reported worse-than-expected quarterly revenue results.
Surgery Partners, Inc. SGRY fell 9.6% to $23.00 in pre-market trading.
Zeta Global Holdings Corp. ZETA dipped 9.1% to $18.73 in pre-market trading after the company issued first-quarter revenue guidance below estimates.